Литература

1. Cecconi M, De Backer D, Antonelli M et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine // Intensive Care Med 2014; 40: 1795-1815

2. Кузьков В.В., Киров М.Ю. Инвазивный мониторинг гемодинамики в интенсивной терапии и анестезиологии. Архангельск : Северный гос. мед. ун-т, 2015. 390 с

3. Vincent J.-L., De Backer D. Circulatory shock // N. Engl. J. Med. 2013. Vol. 369. P. 1726–1734.

4. Standl T, Annecke T, Cascorbi I, Heller AR, Sabashnikov A, Teske W: The nomenclature, definition and distinction of types of shock. Dtsch Arztebl Int 2018; 115: 757–68

5. К.М. Лебединский, М.Ю. Киров, В.В. Кузьков, А.Л. Левит, Е.В. Григорьев, И.Н. Лейдерман. Гл. 2.10. Шок: классификация, диагностика и лечение // В кн.: Интенсивная терапия: национальное руководство : в 2 т. / под ред. И. Б. Заболотских, Д. Н. Проценко. — 2-е изд., перераб. и доп. — Москва : ГЭОТАР-Медиа, 2020. — Т. 1. — 1136 с. : ил. — (Серия «Национальные руководства»). — DOI: 10.33029/9704-5017-8-ICNG-2020-1-1136.

6. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89.

7. Berg DD, Bohula EA, Morrow DA. Epidemiology and causes of cardiogenic shock. Curr Opin Crit Care. 2021 Aug 1;27(4):401-408

8. Cordemans C., De laet I., Van Regenmortel N. et al. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance // Ann. Intensive Care. 2012. Vol. 2, suppl. 1. P. 1.

9. Hoste E.A., Maitland K., Brudney C.S. et al.; ADQI XII Investigators Group. Four phases of intravenous fluid therapy: a conceptual model // Br. J. Anaesth. 2014. Vol. 113. P. 740–747.

10. Teasdale G., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81-4. doi:10.1016/s0140-6736(74)91639-0.

11. Sessler DI. Perioperative Temperature Monitoring. Anesthesiology. 2021;134(1):111-118. doi:10.1097/ALN.0000000000003481

12. Ait-Oufella H. et al. Mottling score predicts survival in septic shock // Intensive Care Med (2011) 37:801–807

13. Lehman LW, Saeed M, Talmor D, Mark R, Malhotra A. Methods of blood pressure measurement in the ICU. Crit Care Med. 2013;41(1):34-40. doi:10.1097/CCM.0b013e318265ea46

14. Анестезия Рональда Миллера - руководство в 4-х томах - Р. Миллер. Пер. под ред. К.М. Лебединского, 2015. ISBN: 978-5-93339-283-5

15. Кузьков В.В., Киров М.Ю. Инвазивный мониторинг гемодинамики в интенсивной терапии и анестезиологии: монография — Изд-е второе, перераб. и доп. — Архангельск: Северный государственный медицинский университет, 2015. — 392 с.

16. Shubin H, Weil MH, Afifi AA, Portigal L, Chang P Selection of hemodynamic, respiratory and metabolic variables for evaluation of patients in shock. Crit Care Med 2326-336, 1974

17. Ghanpur R, Santamaria J, Dixon B: Plastic blood gas syringes and measurement error in central venous oxygen saturations // Shock 46:287–289, 2016.

18. Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. Published 2019 Mar 27. doi:10.1186/s13054-019-2347-3

19. Weil MH, Henning RJ. New concepts in the diagnosis and fluid treatment of circulatory shock. Anesth Analg. 1979;58:124–132

20. Michard F, Boussat S, Chemla D, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000;162:134–138

21. Weil MH, Shubin H. The “VIP” approach to the bedside management of shock // JAMA 1969; 207: 337-340

22. Starchuk E, Weil MH, Shubin H: Fluid Challenge in Critical Care Medicine Handbook. New York, John N Kolen, 1974, pp 17

23. Cecconi M, Hofer C, Teboul JL, et al. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med. 2015;41:1529–1537

24. Arias J, Levy B, De Backer D. Fifty Years of Management of Vasodilatory Shock. Int Anesthesiol Clin. 2019;57(2):31-47. doi:10.1097/AIA.0000000000000226

25. Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of Refractory Vasodilatory Shock. Chest. 2018;154(2):416-426. doi:10.1016/j.chest.2017.12.021

26. Bassi E, Park M, Azevedo LC. Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract. 2013;2013: 654708.

27. Benbenishty J, Weissman C, Sprung CL, Brodsky-Israeli M, Weiss Y. Characteristics of patients receiving vasopressors. Heart Lung. 2011;40(3):247-252.

28. Brown SM, Lanspa MJ, Jones JP, et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013;143(3):664-671.]

29. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA.; 315(8): 801-10. http://doi:10.1001/jama.2016.028

30. Shankar-Hari M., Phillips G.S., Levy M.L., et al. Developing a new definition and assessing new clinical criteria for Septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315(8): 775-87. doi: 10.1001/jama.2016.0289

31. Seymour C.W., Kennedy J.N., Wang S., et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019; 321(20): 2003-2017. doi: 10.1001/jama.2019.5791

32. Bermejo-Martin J.F., Martín-Fernandez M., López-Mestanza C., et al. Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease). J Clin Med. 2018; 7(11): 400. doi: 10.3390/jcm7110400

33. López-Aguirre Y., Páramo J.A. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res. 1999; 94(2): 95-101. doi: 10.1016/s0049-3848(98)00200-x

34. Lenney M., Kopp B., Erstad B. Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock. Am J Health Syst Pharm. 2022 Aug 19;79(Suppl 3):S94-S99. doi: 10.1093/ajhp/zxac156

35. Meresse Z., Medam S., Mathieu C., Duclos G et al. Vasopressors to treat refractory septic shock. Minerva Anestesiol. 2020 May;86(5):537-545. doi: 10.23736/S0375-9393.20.13826-4

36. Nandhabalan P., Ioannou N., Meadows C., Wyncoll D. Refractory septic shock: our pragmatic approach. Crit Care. 2018 Sep 19;22(1):215. doi: 10.1186/s13054-018-2144-4

37. Ryan K, Martin Caravati E. Life-threatening anaphylaxis following envenomation by two different species of Crotalidae. J Wilderness Med. 1994;5(3):263-268. doi:10.1580/0953-9859-5.3.263

38. Ильина Н.И., Заболотских И.Б., Астафьева Н.Г. и соавт. Анафилактический шок (2-й пересмотр). Клинические рекомендации. М. 2023, 33 с.

39. American College of Surgeons Committee on Trauma. Advanced Trauma Life Support (ATLS) Student Course Manual. 9th ed. Chicago : American College of Surgeons, 2012. 69 c.

40. Cannon J.W. Hemorrhagic shock // N. Engl. J. Med. 2018. Vol. 378. P. 370–379.

41. Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023 Mar 1;27(1):80

42. Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, et al. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014;259(2):255-62

43. Paradis NA, et al. Hematocrit as a predictor of significant injury after penetrating trauma. Am J Emerg Med. 1997;15(3):224-228.

44. Zehtabchi S, Sinert R, Goldman M, Kapitanyan R, Ballas J. Diagnostic performance of serial haematocrit measurements in identifying major injury in adult trauma patients. Injury. 2006;37(1):46-52.

45. Schlimp CJ, et al. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care. 2013;17(4):R137.

46. Cotton BA, Dossett LA, Haut ER, et al. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010; 69 (Suppl 1):S33–S39.

47. Chang R., Holcomb J.B. Optimal Fluid Therapy for Traumatic Hemorrhagic Shock //Crit Care Clin. 2017; 33 (1): 15–36

48. Roberts I et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients // Health Technol Assess. 2013 Mar;17(10):1-79

49. Tsuei BJ, Kearney PA. Hypothermia in the trauma patient. Injury 2004;35:7–15.

50. Kirov M.Y. et al. (eds.), Advanced Hemodynamic Monitoring: Basics and New Horizons, 2021, https://doi.org/10.1007/978-3-030-71752-0_23

51. Chytra I, Pradl R, Bosman R, Pelnár P, Kasal E, Zidková A. Esophageal Doppler-guided fluid management decreases blood lactate levels in multipletrauma patients: a randomized controlled trial. Crit Care. 2007;11(1):R24.

52. Щеголев А.В., Климов А.Г. Термическая травма // В кн.: Интенсивная терапия: национальное руководство : в 2 т. / под ред. И. Б. Заболотских, Д. Н. Проценко. — 2-е изд., перераб. и доп. — Москва : ГЭОТАР-Медиа, 2020. — Т. 1. — 1136 с. : ил. — (Серия «Национальные руководства»). — DOI: 10.33029/9704-5017-8-ICNG-2020-1-1136.

53. Григорьев Е.В., Баутин А.Е., Киров М.Ю., Шукевич Д.Л., Корнелюк Р.А. Кардиогенный шок при остром коронарном синдроме: современное состояние проблемы диагностики и интенсивной терапии. Вестник интенсивной терапии им. А.И. Салтанова. 2020;2:73–85.

54. Ponikowski P., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37: 2129–2200

55. Tehrani BN et al. A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock. JACC Heart Fail. 2020 Nov;8(11):879-891.

56. Berg DD, Bohula EA, Morrow DA. Epidemiology and causes of cardiogenic shock. Curr Opin Crit Care. 2021 Aug 1;27(4):401-408

57. Baran DA et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37

58. Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022 Mar 8;79(9):933-946.

59. Zeymer U., et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9(2): 183–197

60. Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40(32):2671-2683. doi:10.1093/eurheartj/ehz363

61. Степаненко С.М. Острая недостаточность кровообращения // В кн.: Интенсивная терапия: национальное руководство : в 2 т. / под ред. И. Б. Заболотских, Д. Н. Проценко. — 2-е изд., перераб. и доп. — Москва : ГЭОТАР-Медиа, 2020. — Т. 2. — 1056 с. : ил. — (Серия «Национальные руководства»). — DOI: 10.33029/9704-5018-5-ICNG-2020-1-1056.

62. McLean-Tooke A, Bethune C, Fay A, Spickett G. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 2003; 327(7427): p. 1332-1335. Doi:10/1136/bmj.327.7427.1332